Synonyms: AGN-PC-0031SD | ARN-2966
Compound class:
Synthetic organic
Comment: 2-PMAP is an investigational compound for Alzheimer's disease (AD). A recent study has demonstrated that this compound crosses the blood-brain barrier and reduces levels of full-length amyloid precursor protein (APP) and amyloid beta (Aβ) deposition in the brains of AD model mice without causing significant toxicity [1]. This is accompanied by reduced Aβ pathology and rescue of memory deficit in AD model mice via an inhibitory effect on mRNA translation. This compound may exist as a tautomer with PubChem CID 68604369.
|
|
No information available. |
Mechanism Of Action and Pharmacodynamic Effects |
In vitro, 2-PMAP is reported to reduce the steady-state level of APP, thereby limiting cleavage to Aβ [1], but does not affect APP transcription. Further protein translation analysis, reported in this same article, demonstrates that 2-PMAP acts as a selective APP post-transcriptional modulator, although its precise molecular mechanism of action is unclear. |